138 related articles for article (PubMed ID: 27816956)
1. Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
Li G; Hou X; Li Y; Zhang P; Zhao Q; Li J; Shi J
Clin Chem Lab Med; 2017 Jul; 55(8):1090-1099. PubMed ID: 27816956
[TBL] [Abstract][Full Text] [Related]
2. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
[TBL] [Abstract][Full Text] [Related]
4. Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients.
Liao W; Chen Y; Gao Q; Gan R; Li M; Liu Z; Liang J; Cui H; Ren K; Liu Y; Wang Z; Jiang J; Wei Q
Cardiovasc Diabetol; 2023 Dec; 22(1):334. PubMed ID: 38057783
[TBL] [Abstract][Full Text] [Related]
5. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
[TBL] [Abstract][Full Text] [Related]
6. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.
Rasoul S; Ottervanger JP; Bilo HJ; Timmer JR; van 't Hof AW; Dambrink JH; Dikkeschei LD; Hoorntje JC; de Boer MJ; Zijlstra F
Neth J Med; 2007 Mar; 65(3):95-100. PubMed ID: 17387235
[TBL] [Abstract][Full Text] [Related]
7. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.
Pan W; Lu H; Lian B; Liao P; Guo L; Zhang M
Cardiovasc Diabetol; 2019 Dec; 18(1):169. PubMed ID: 31829179
[TBL] [Abstract][Full Text] [Related]
9. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
[TBL] [Abstract][Full Text] [Related]
10. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
[TBL] [Abstract][Full Text] [Related]
11. The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction.
Liu J; Wang S; Cui C; Cai H; Sun R; Pan W; Fang S; Yu B
Cardiovasc Diabetol; 2020 Jul; 19(1):109. PubMed ID: 32641042
[TBL] [Abstract][Full Text] [Related]
12. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
[TBL] [Abstract][Full Text] [Related]
13. Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients.
Ghaffari S; Niafar F; Separham A; Niafar M; Pourafkari L; Nader ND
Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):305-13. PubMed ID: 25976908
[TBL] [Abstract][Full Text] [Related]
14. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Gao S; Liu Q; Ding X; Chen H; Zhao X; Li H
Angiology; 2020 Jan; 71(1):38-47. PubMed ID: 31554413
[TBL] [Abstract][Full Text] [Related]
16. Two-year prognosis of admission hemoglobin A1c following a primary percutaneous coronary intervention.
Çiçek G; Korkmaz A
Coron Artery Dis; 2016 Dec; 27(8):673-681. PubMed ID: 27433996
[TBL] [Abstract][Full Text] [Related]
17. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
Ahn J; Hong TJ; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Cha KS; Yun E; Jeong MH; Chae SC; Kim YJ; Hur SH; Seong IW; Jang YS; Cho MC; Kim CJ; Seung KB; Rha SW; Bae JH; Park SJ;
Coron Artery Dis; 2015 Nov; 26(7):555-61. PubMed ID: 25933028
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
Cicek G; Uyarel H; Ergelen M; Ayhan E; Abanonu GB; Eren M; Gibson CM
Coron Artery Dis; 2011 May; 22(3):131-7. PubMed ID: 21394027
[TBL] [Abstract][Full Text] [Related]
19. Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction.
Aggarwal B; Shah GK; Randhawa M; Ellis SG; Lincoff AM; Menon V
Am J Cardiol; 2016 Mar; 117(5):749-53. PubMed ID: 26768673
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of HbA1c and plasma glucose on one-year mortality in non-diabetic patients after myocardial infarction].
Gueniat-Ratheau E; Yao H; Debeaumarche H; Maalem B; Lairet C; Maza M; Bichat F; Zeller M; N'Guetta R; Cottin Y
Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):180-191. PubMed ID: 32854906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
